Updated on 8 August 2014
The findings of the survey will be published in the September issue of BioSpectrum Asia
Singapore: BioSpectrum Asia will highlight a whole host of issues facing the industry, while tracking the trends of the Asia Pacific region in its annual CRO survey this September. "In an effort to assess the ecosystem trends in Contract and Clinical Research Organizations (CROs) in the Asia Pacific region, we have been conducting an annual survey of the CRO industry since 2009," explained Mr Narayanan Suresh, Group Editor - BioSpectrum (India &Asia).
The survey this year will highlight the growth and challenges faced by the industry in various Asian nations. The scope of the study will include perceptions of the industry as well as its performance.
The findings of the survey will be published in the September issue and will include insights shared by the CEOs of CROs across the region.
The survey will prioritize the policy changes in the clinical research sector in the last one year, the major newsmakers in the Asian market, the growing interest of MNC CROs in the local market through mergers or acquisitions. It would also simplify the data generated through the survey using a geographical mapping of clinical trials in Asia for major diseases. It will also explore country specific funding and investment trends.
To participate in the coveted survey, please fill in the following survey form: